Fingerprint
Dive into the research topics of 'Preclinical evaluations of therapies combining the vascular targeting agent combretastatin A-4 disodium phosphate and conventional anticancer therapies in the treatment of Kaposi's sarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically